FREDRIC N ESHELMAN Insider Trading $PPDI PHARMACEUTICAL PRODUCT DEVELOPMENT INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for FREDRIC N ESHELMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of FREDRIC N ESHELMAN. FREDRIC N ESHELMAN is Director in Valeant Pharmaceuticals International, Inc. ($BVF) and CEO in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Chief Executive Officer in PHARMACEUTICAL PRODUCT DEVELOPMENT INC ($PPDI) and Director in MEDICINES CO /DE ($MDCO) and Executive Chairman in MEDICINES CO /DE ($MDCO) and Director in Aravive, Inc. ($ARAV) and Director in G1 Therapeutics, Inc. ($GTHX) and Director in EYENOVIA, INC. ($EYEN).
FREDRIC N ESHELMAN in PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of FREDRIC N ESHELMAN: CEO, Chief Executive Officer
Holdings: 7,965,626 shares
Latest Transaction: Aug 29 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of FREDRIC N ESHELMAN in PHARMACEUTICAL PRODUCT DEVELOPMENT INC
Sentiment: All, ARAV, BVF, EYEN, GTHX, MDCO, PPDI
Page: < prev 1 ... 2 3 4 5 6 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.45 | 100 | 3,345 | 9,185,560 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.41 | 100 | 3,341 | 9,185,660 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.40 | 100 | 3,340 | 9,185,760 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.39 | 200 | 6,678 | 9,185,860 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.38 | 16 | 534 | 9,186,060 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.37 | 184 | 6,140 | 9,186,076 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.36 | 300 | 10,008 | 9,186,260 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.35 | 512 | 17,075 | 9,186,560 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.34 | 588 | 19,604 | 9,187,072 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.33 | 1,312 | 43,729 | 9,187,660 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.32 | 488 | 16,260 | 9,188,972 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.31 | 1,300 | 43,303 | 9,189,460 | 9.2 M to 9.2 M (-0.01 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.41 | 4,633 | 145,523 | 9,131,827 | 9.1 M to 9.1 M (-0.05 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.40 | 4,600 | 144,440 | 9,136,460 | 9.1 M to 9.1 M (-0.05 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.39 | 7,987 | 250,712 | 9,141,060 | 9.1 M to 9.1 M (-0.09 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.38 | 3,655 | 114,694 | 9,149,047 | 9.2 M to 9.1 M (-0.04 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.37 | 4,058 | 127,299 | 9,152,702 | 9.2 M to 9.2 M (-0.04 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.36 | 6,000 | 188,160 | 9,156,760 | 9.2 M to 9.2 M (-0.07 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.35 | 2,500 | 78,375 | 9,162,760 | 9.2 M to 9.2 M (-0.03 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.34 | 1,600 | 50,144 | 9,165,260 | 9.2 M to 9.2 M (-0.02 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.33 | 500 | 15,665 | 9,166,860 | 9.2 M to 9.2 M (-0.01 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.32 | 2,300 | 72,036 | 9,167,360 | 9.2 M to 9.2 M (-0.03 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.31 | 1,400 | 43,834 | 9,169,660 | 9.2 M to 9.2 M (-0.02 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.30 | 2,600 | 81,380 | 9,171,060 | 9.2 M to 9.2 M (-0.03 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.29 | 1,600 | 50,064 | 9,173,660 | 9.2 M to 9.2 M (-0.02 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.28 | 300 | 9,384 | 9,175,260 | 9.2 M to 9.2 M (0.00 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.27 | 400 | 12,508 | 9,175,560 | 9.2 M to 9.2 M (0.00 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.26 | 500 | 15,630 | 9,175,960 | 9.2 M to 9.2 M (-0.01 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.25 | 1,400 | 43,750 | 9,176,460 | 9.2 M to 9.2 M (-0.02 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.24 | 700 | 21,868 | 9,177,860 | 9.2 M to 9.2 M (-0.01 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.23 | 894 | 27,920 | 9,178,560 | 9.2 M to 9.2 M (-0.01 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.22 | 106 | 3,309 | 9,179,454 | 9.2 M to 9.2 M (0.00 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.21 | 700 | 21,847 | 9,179,560 | 9.2 M to 9.2 M (-0.01 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.20 | 900 | 28,080 | 9,180,260 | 9.2 M to 9.2 M (-0.01 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.19 | 200 | 6,238 | 9,181,160 | 9.2 M to 9.2 M (0.00 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.18 | 500 | 15,590 | 9,181,360 | 9.2 M to 9.2 M (-0.01 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.17 | 1,100 | 34,287 | 9,181,860 | 9.2 M to 9.2 M (-0.01 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.16 | 500 | 15,580 | 9,182,960 | 9.2 M to 9.2 M (-0.01 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.15 | 100 | 3,115 | 9,183,460 | 9.2 M to 9.2 M (0.00 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.13 | 92 | 2,864 | 9,183,560 | 9.2 M to 9.2 M (0.00 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.12 | 232 | 7,220 | 9,183,652 | 9.2 M to 9.2 M (0.00 %) |
| Mar 05 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 31.06 | 76 | 2,361 | 9,183,884 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.94 | 1,600 | 52,704 | 9,223,760 | 9.2 M to 9.2 M (-0.02 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.93 | 900 | 29,637 | 9,225,360 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.92 | 1,500 | 49,380 | 9,226,260 | 9.2 M to 9.2 M (-0.02 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.91 | 500 | 16,455 | 9,227,760 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.90 | 1,100 | 36,190 | 9,228,260 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.89 | 700 | 23,023 | 9,229,360 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.88 | 300 | 9,864 | 9,230,060 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.87 | 900 | 29,583 | 9,230,360 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.86 | 1,000 | 32,860 | 9,231,260 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.85 | 400 | 13,140 | 9,232,260 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.84 | 4,400 | 144,496 | 9,232,660 | 9.2 M to 9.2 M (-0.05 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.83 | 3,300 | 108,339 | 9,237,060 | 9.2 M to 9.2 M (-0.04 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.82 | 2,400 | 78,768 | 9,240,360 | 9.2 M to 9.2 M (-0.03 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.81 | 1,200 | 39,372 | 9,242,760 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.80 | 2,300 | 75,440 | 9,243,960 | 9.2 M to 9.2 M (-0.02 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.79 | 8,200 | 268,878 | 9,246,260 | 9.3 M to 9.2 M (-0.09 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.78 | 1,213 | 39,762 | 9,254,460 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.77 | 1,045 | 34,245 | 9,255,673 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.76 | 1,600 | 52,416 | 9,256,718 | 9.3 M to 9.3 M (-0.02 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.75 | 2,675 | 87,606 | 9,258,318 | 9.3 M to 9.3 M (-0.03 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.74 | 700 | 22,918 | 9,260,993 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.73 | 800 | 26,184 | 9,261,693 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.72 | 1,000 | 32,720 | 9,262,493 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.71 | 700 | 22,897 | 9,263,493 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.70 | 1,000 | 32,700 | 9,264,193 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.69 | 500 | 16,345 | 9,265,193 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.68 | 500 | 16,340 | 9,265,693 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.67 | 500 | 16,335 | 9,266,193 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.66 | 500 | 16,330 | 9,266,693 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.65 | 100 | 3,265 | 9,267,193 | 9.3 M to 9.3 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.30 | 2,300 | 76,590 | 9,190,760 | 9.2 M to 9.2 M (-0.03 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.28 | 300 | 9,984 | 9,193,060 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.27 | 600 | 19,962 | 9,193,360 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.26 | 700 | 23,282 | 9,193,960 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.24 | 200 | 6,648 | 9,194,660 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.23 | 100 | 3,323 | 9,194,860 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.22 | 500 | 16,610 | 9,194,960 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.21 | 300 | 9,963 | 9,195,460 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.20 | 100 | 3,320 | 9,195,760 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.19 | 100 | 3,319 | 9,195,860 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.18 | 100 | 3,318 | 9,195,960 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.16 | 800 | 26,528 | 9,196,060 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.15 | 1,100 | 36,465 | 9,196,860 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.14 | 1,177 | 39,006 | 9,197,960 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.13 | 2,943 | 97,502 | 9,199,137 | 9.2 M to 9.2 M (-0.03 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.12 | 5,780 | 191,434 | 9,209,080 | 9.2 M to 9.2 M (-0.06 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.11 | 2,272 | 75,226 | 9,207,860 | 9.2 M to 9.2 M (-0.02 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.10 | 2,647 | 87,616 | 9,210,132 | 9.2 M to 9.2 M (-0.03 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.09 | 2,381 | 78,787 | 9,212,779 | 9.2 M to 9.2 M (-0.03 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.08 | 2,000 | 66,160 | 9,215,160 | 9.2 M to 9.2 M (-0.02 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.07 | 1,600 | 52,912 | 9,217,160 | 9.2 M to 9.2 M (-0.02 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.06 | 800 | 26,448 | 9,218,760 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.05 | 100 | 3,305 | 9,219,560 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.04 | 1,200 | 39,648 | 9,219,660 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.03 | 800 | 26,424 | 9,220,860 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.02 | 900 | 29,718 | 9,221,660 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.01 | 200 | 6,602 | 9,222,560 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.00 | 400 | 13,200 | 9,222,760 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.96 | 100 | 3,296 | 9,223,160 | 9.2 M to 9.2 M (0.00 %) |
| Feb 27 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 32.95 | 500 | 16,475 | 9,223,260 | 9.2 M to 9.2 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.62 | 900 | 30,258 | 9,267,293 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.61 | 1,300 | 43,693 | 9,268,193 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.60 | 900 | 30,240 | 9,269,493 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.59 | 100 | 3,359 | 9,270,393 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.58 | 400 | 13,432 | 9,270,493 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.57 | 800 | 26,856 | 9,270,893 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.56 | 200 | 6,712 | 9,271,693 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.55 | 400 | 13,420 | 9,271,893 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.54 | 5,000 | 167,700 | 9,272,293 | 9.3 M to 9.3 M (-0.05 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.53 | 300 | 10,059 | 9,277,293 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.52 | 2,600 | 87,152 | 9,277,593 | 9.3 M to 9.3 M (-0.03 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.51 | 1,700 | 56,967 | 9,280,193 | 9.3 M to 9.3 M (-0.02 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.50 | 1,100 | 36,850 | 9,281,893 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.49 | 9,433 | 315,911 | 9,282,993 | 9.3 M to 9.3 M (-0.10 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.48 | 6,900 | 231,012 | 9,292,426 | 9.3 M to 9.3 M (-0.07 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.47 | 1,400 | 46,858 | 9,299,326 | 9.3 M to 9.3 M (-0.02 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.46 | 700 | 23,422 | 9,300,726 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.45 | 200 | 6,690 | 9,301,426 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.44 | 300 | 10,032 | 9,301,626 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.43 | 500 | 16,715 | 9,301,926 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.42 | 1,900 | 63,498 | 9,302,426 | 9.3 M to 9.3 M (-0.02 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.41 | 1,400 | 46,774 | 9,304,326 | 9.3 M to 9.3 M (-0.02 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.40 | 3,900 | 130,260 | 9,305,726 | 9.3 M to 9.3 M (-0.04 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.39 | 2,528 | 84,410 | 9,309,626 | 9.3 M to 9.3 M (-0.03 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.38 | 8,272 | 276,119 | 9,312,154 | 9.3 M to 9.3 M (-0.09 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.37 | 8,600 | 286,982 | 9,320,426 | 9.3 M to 9.3 M (-0.09 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.36 | 4,000 | 133,440 | 9,329,026 | 9.3 M to 9.3 M (-0.04 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.35 | 2,600 | 86,710 | 9,333,026 | 9.3 M to 9.3 M (-0.03 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.34 | 2,500 | 83,350 | 9,335,626 | 9.3 M to 9.3 M (-0.03 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.33 | 600 | 19,998 | 9,338,126 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.32 | 1,513 | 50,413 | 9,338,726 | 9.3 M to 9.3 M (-0.02 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.31 | 987 | 32,877 | 9,340,239 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.30 | 500 | 16,650 | 9,341,226 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.29 | 2,900 | 96,541 | 9,341,726 | 9.3 M to 9.3 M (-0.03 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.28 | 1,500 | 49,920 | 9,344,626 | 9.3 M to 9.3 M (-0.02 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.27 | 829 | 27,581 | 9,346,126 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.26 | 384 | 12,772 | 9,346,955 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.25 | 687 | 22,843 | 9,347,339 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.24 | 300 | 9,972 | 9,348,026 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.23 | 600 | 19,938 | 9,348,326 | 9.3 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.22 | 100 | 3,322 | 9,348,926 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.21 | 400 | 13,284 | 9,349,026 | 9.3 M to 9.3 M (0.00 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.20 | 800 | 26,560 | 9,349,426 | 9.4 M to 9.3 M (-0.01 %) |
| Feb 21 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 33.19 | 400 | 13,276 | 9,350,226 | 9.4 M to 9.4 M (0.00 %) |
| Feb 23 2007 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Option Exercise | A | 33.61 | 50,000 | 1,680,500 | 50,000 | |
| Dec 18 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Gift | G | 0.00 | 74,492 | 0 | 9,350,626 | 9.4 M to 9.4 M (-0.79 %) |
| May 19 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Payment of Exercise | F | 35.96 | 5,408 | 194,472 | 9,425,118 | 9.4 M to 9.4 M (-0.06 %) |
| May 17 2006 | PPDI | PHARMACEUTICAL PRO ... | ESHELMAN FREDRIC N | CEO | Sell | S | 36.68 | 1,614 | 59,202 | 9,442,706 | 9.4 M to 9.4 M (-0.02 %) |